de Verneuil Vanina
SEC CIK 2036234 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | EVP, GC, Corp Sec | 126.7K | — | $411.0K | 11 | 2024-11-01 | 2026-02-24 |
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-26 | 2026-02-24+ | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $9.77 | -16.8K | 126.7K | -12% | -$164.2K |
| D | 2026-02-24 | 2026-02-22 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC, Corp Sec | A - Grant | $0.00 | +55.0K | 134.2K | +69% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $7.45 | -4,445 | 129.8K | -3% | -$33.1K |
| 2025-11-07 | 2025-11-05 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $5.16 | -2,385 | 78.2K | -3% | -$12.3K | |
| 2025-11-04 | 2025-11-03 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | S - Sale | $5.86 | -1,365 | 80.6K | -2% | -$7,999 | |
| 2025-02-27 | 2025-02-26 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | S - Sale | $9.14 | -7,373 | 79.5K | -8% | -$67.4K | |
| D | 2025-02-25 | 2025-02-22 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | A - Grant | $0.00 | +35.0K | 92.0K | +61% | $0 |
| D | 2025-02-25 | 2025-02-24 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | S - Sale | $9.45 | -5,140 | 86.8K | -6% | -$48.6K |
| 2024-12-04 | 2024-12-02 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | S - Sale | $8.22 | -76 | 57.0K | -0.1% | -$624.72 | |
| 2024-11-07 | 2024-11-06 | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | S - Sale | $10.11 | -4,397 | 57.0K | -7% | -$44.5K | |
| M | 2024-11-05 | 2024-11-01+ | VIR | Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, GC | S - Sale | $8.62 | -3,750 | 63.7K | -6% | -$32.3K |
Purchase Sale Sale after option exercise All abbreviations